ibi939
mAbexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2013 (NCT02854111)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
TIGIT inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04672369 | Phase 1 | Jun 6, 2021 | Innovent Biologics (Suzhou) Co. Ltd., Jilin University |
| NCT04672356 | Phase 1 | Jan 28, 2021 | Innovent Biologics (Suzhou) Co. Ltd., Jilin University |
| NCT04353830 | Phase 1 | May 22, 2020 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT04439981 | N/A | Apr 8, 2019 | Universitas Muhammadiyah Semarang |
| NCT02854111 | N/A | Jul 31, 2013 | Mahidol University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | For profit | 3 | 3 | 1 | 2020 |
| Jilin University | Academic/Hospital | 2 | 0 | 1 | 2021 |
| Mahidol University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Universitas Muhammadiyah Semarang | Academic/Hospital | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1